Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.85) per share. This is a 90.51 percent increase over losses of $(8.96) per share from the same period last year.
Bill Hwang’s Trial Begins Over Archegos Fund Collapse: What To Expect
Bill Hwang's trial for stock manipulation began in New York. He and his deputy face charges related to the collapse of their investment fund, causing over $100 billion in losses.
